IGF2R, insulin like growth factor 2 receptor, 3482

N. diseases: 166; N. variants: 18
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013264
Disease: Muscular Dystrophy, Duchenne
Muscular Dystrophy, Duchenne
0.010 Biomarker disease BEFREE Blockade of IGF2R by neutralizing antibodies stimulated muscle regeneration, induced force recovery and normalized capillary architecture in dystrophic mdx mice representing an encouraging starting point for the development of new biological therapies for DMD. 31793167 2020
Secondary malignant neoplasm of lymph node
0.010 AlteredExpression disease BEFREE Immunohistochemistry (IHC) and Cox regression analysis showed low IGF2R expression were significantly associated with more advanced histological grade; high clinical stage; lymph node metastasis and poorer overall survival for patients with bladder cancer. 31847523 2020
CUI: C0007847
Disease: Malignant tumor of cervix
Malignant tumor of cervix
0.010 AlteredExpression disease BEFREE Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. 31748500 2019
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.010 AlteredExpression disease BEFREE The protein expression level of IGF2, IGF1R and IGF2R was evaluated by immunohistochemistry in 17 human ACCs and the mRNA expression level of IGF1, IGF2, IGF1R, IR isoforms A and B, IGF2R, IGF-Binding-Proteins[IGFBP]-1, 2, 3 and 6 was evaluated by RT-qPCR in 12 samples. 30838516 2019
CUI: C0282160
Disease: Aplasia Cutis Congenita
Aplasia Cutis Congenita
0.010 AlteredExpression disease BEFREE The protein expression level of IGF2, IGF1R and IGF2R was evaluated by immunohistochemistry in 17 human ACCs and the mRNA expression level of IGF1, IGF2, IGF1R, IR isoforms A and B, IGF2R, IGF-Binding-Proteins[IGFBP]-1, 2, 3 and 6 was evaluated by RT-qPCR in 12 samples. 30838516 2019
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 AlteredExpression disease BEFREE Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. 31748500 2019
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor
0.010 Biomarker phenotype BEFREE The present study focused on the effects of the expression of the tumor suppressor gene insulin‑like growth factor‑2 receptor (IGF2R) on patient survival and tumor recurrence in patients with HCC; this study paid specific attention to the influence of transarterial chemoembolization (TACE) prior to surgery. 30720132 2019
CUI: C1142339
Disease: Intestinal adenoma
Intestinal adenoma
0.010 AlteredExpression disease BEFREE Bi-allelic Igf2r expression suppressed intestinal adenoma (Apc<sup>Min</sup>). 31388182 2019
CUI: C1292753
Disease: Primary Effusion Lymphoma
Primary Effusion Lymphoma
0.010 AlteredExpression disease BEFREE We show in the present study that vIL-6 can promote productive replication and latent PEL cell viability through upregulation of the mannose-6-phosphate- and peptide hormone-interacting receptor IGF2R, which is a positive factor in HHV-8 biology via these activities. 30541844 2019
CUI: C1623038
Disease: Cirrhosis
Cirrhosis
0.010 AlteredExpression disease BEFREE RT‑PCR demonstrated that the mRNA expression levels of IGF2R were downregulated in HCC compared with in TST samples (P=0.004), which was associated with a worse recurrence‑free survival of patients with HCC (P=0.002) and a lower occurrence of cirrhosis (P=0.05). 30720132 2019
CUI: C1709246
Disease: Non-Neoplastic Disorder
Non-Neoplastic Disorder
0.010 AlteredExpression disease BEFREE The mRNA expression levels of IGF2R were measured in primary human HCC and corresponding non‑neoplastic tumor‑surrounding tissue (TST) by reverse transcription‑polymerase chain reaction (RT‑PCR) (n=92). 30720132 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.010 AlteredExpression disease BEFREE Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. 31748500 2019
Obesity-Associated Insulin Resistance
0.010 Biomarker disease BEFREE Our results characterize the miR-143-3p-IGF2R pathway as a potential target for the treatment of obesity-associated insulin resistance. 30392876 2019
CUI: C0002962
Disease: Angina Pectoris
Angina Pectoris
0.010 Biomarker phenotype BEFREE Fifty patients with angina (65 ± 9 years of age) and 20 age-matched healthy control subjects underwent adenosine stress CMR (1.5- and 3-T) to assess left ventricular function, inducible ischemia (myocardial perfusion reserve index [MPRI]; myocardial blood flow [MBF]), and infarction (late gadolinium enhancement). 29495996 2018
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE However, the role of insulin receptor (IR) isoforms, IGF-IR or insulin-like growth factor-II receptor (IGF-IIR) in VSMCs apoptosis during advanced atherosclerosis remains unclear. 29463262 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE However, the role of insulin receptor (IR) isoforms, IGF-IR or insulin-like growth factor-II receptor (IGF-IIR) in VSMCs apoptosis during advanced atherosclerosis remains unclear. 29463262 2018
CUI: C0018799
Disease: Heart Diseases
Heart Diseases
0.010 AlteredExpression group BEFREE The insulin-like growth factor type 2 receptor (IGF2R) overexpression has been implicated in heart disease progression. 29136764 2018
CUI: C0018801
Disease: Heart failure
Heart failure
0.010 Biomarker disease BEFREE The current review discusses about the expression, structure, and functional role of E4BP4 in signaling processes with emphasis on calcium signaling mechanisms, autocrine signaling, and insulin-like growth factor II receptor-mediated processes regulated by E4BP4 that may regulate the pathogenesis of HF. 29856483 2018
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.010 Biomarker disease BEFREE The current review discusses about the expression, structure, and functional role of E4BP4 in signaling processes with emphasis on calcium signaling mechanisms, autocrine signaling, and insulin-like growth factor II receptor-mediated processes regulated by E4BP4 that may regulate the pathogenesis of HF. 29856483 2018
CUI: C0023895
Disease: Liver diseases
Liver diseases
0.010 Biomarker group BEFREE Soluble CD222 has been found in higher concentrations in sera of liver disease patients. 29940770 2018
CUI: C0025309
Disease: Meningoencephalitis
Meningoencephalitis
0.010 AlteredExpression disease BEFREE This study contributes to a deeper understanding of the molecular regulation of Mpr1 activity and may lead to the development of specific inhibitors that could be used to restrict fungal penetration of the CNS and thus prevent cryptococcal meningoencephalitis-related deaths. 30161190 2018
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.010 AlteredExpression disease BEFREE The urine CD222 levels were increased specifically in breast cancer and multiple myeloma. 29940770 2018
CUI: C0151744
Disease: Myocardial Ischemia
Myocardial Ischemia
0.010 Biomarker disease BEFREE Fifty patients with angina (65 ± 9 years of age) and 20 age-matched healthy control subjects underwent adenosine stress CMR (1.5- and 3-T) to assess left ventricular function, inducible ischemia (myocardial perfusion reserve index [MPRI]; myocardial blood flow [MBF]), and infarction (late gadolinium enhancement). 29495996 2018
CUI: C0151779
Disease: Cutaneous Melanoma
Cutaneous Melanoma
0.010 GeneticVariation disease BEFREE Compared to CM, which showed frequent mutations in known driver genes (BRAF 50.0%, NRAS 29.2%), MM displayed lower mutation frequencies (BRAF; 12.2%, p < 0.001, NRAS; 17.1%), and was significantly more enriched for triple wild-type (no mutations in BRAF, RAS, or NF1, 70.7% vs 25.0%, p < 0.001), IGF2R mutation (31.7% vs 6.3%, p = 0.002), and KIT mutation (9.8% vs 0%, p = 0.042). 30373548 2018
CUI: C0205770
Disease: Choroid Plexus Papilloma
Choroid Plexus Papilloma
0.010 Biomarker disease BEFREE BMI in the CPP group was associated with IGF-2(3580), IGF1R, and the combinations of [IGF-2(3580) + IGF2R], and [IGF-2(3580) + IGFBP-3]. 30249230 2018